These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15821508)

  • 1. Physicochemical metabolic characteristics for calcium oxalate stone formation in patients with gouty diathesis.
    Pak CY; Moe OW; Sakhaee K; Peterson RD; Poindexter JR
    J Urol; 2005 May; 173(5):1606-9. PubMed ID: 15821508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis.
    Pak CY; Poindexter JR; Peterson RD; Koska J; Sakhaee K
    Urology; 2002 Nov; 60(5):789-94. PubMed ID: 12429297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical profile of stone-forming patients with diabetes mellitus.
    Pak CY; Sakhaee K; Moe O; Preminger GM; Poindexter JR; Peterson RD; Pietrow P; Ekeruo W
    Urology; 2003 Mar; 61(3):523-7. PubMed ID: 12639639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium oxalate stone and gout.
    Marickar YM
    Urol Res; 2009 Dec; 37(6):345-7. PubMed ID: 19779706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and biochemical presentation of gouty diathesis: comparison of uric acid versus pure calcium stone formation.
    Khatchadourian J; Preminger GM; Whitson PA; Adams-Huet B; Pak CY
    J Urol; 1995 Nov; 154(5):1665-9. PubMed ID: 7563316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
    Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
    Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and dietary factors of uric acid stone formation.
    Trinchieri A; Montanari E
    Urolithiasis; 2018 Apr; 46(2):167-172. PubMed ID: 28246885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the metabolic profile of mixed calcium oxalate/uric acid stone formers to that of pure calcium oxalate and pure uric acid stone formers.
    Friedlander JI; Moreira DM; Hartman C; Elsamra SE; Smith AD; Okeke Z
    Urology; 2014 Aug; 84(2):289-94. PubMed ID: 24929942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gout, stone composition and urinary stone risk: a matched case comparative study.
    Marchini GS; Sarkissian C; Tian D; Gebreselassie S; Monga M
    J Urol; 2013 Apr; 189(4):1334-9. PubMed ID: 23022002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gouty diathesis and sarcoidosis in patient with recurrent calcium nephrolithiasis.
    Harvey JA; Pak CY
    J Urol; 1988 Jun; 139(6):1287-9. PubMed ID: 3373603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients.
    Murayama T; Sakai N; Yamada T; Takano T
    Int J Urol; 2001 Oct; 8(10):525-31; discussion 532. PubMed ID: 11737477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dietary modification on urinary stone risk factors.
    Pak CY; Odvina CV; Pearle MS; Sakhaee K; Peterson RD; Poindexter JR; Brinkley LJ
    Kidney Int; 2005 Nov; 68(5):2264-73. PubMed ID: 16221228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
    Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
    Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
    Pak CY; Peterson R
    Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic values of urinary citrate for kidney stones in patients with primary gout].
    Wang Y; Zhang HM; Deng XR; Liu WW; Chen L; Zhao N; Zhang XH; Song ZB; Geng Y; Ji LL; Wang Y; Zhang ZL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1134-1140. PubMed ID: 36533345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors.
    Schwille PO; Wipplinger J
    Eur J Med Res; 2008 Jul; 13(7):332-42. PubMed ID: 18700191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperuricosuria and urolithiasis].
    Koide T
    Nihon Rinsho; 1996 Dec; 54(12):3273-6. PubMed ID: 8976104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cranberry juice consumption on urinary stone risk factors.
    Gettman MT; Ogan K; Brinkley LJ; Adams-Huet B; Pak CY; Pearle MS
    J Urol; 2005 Aug; 174(2):590-4; quiz 801. PubMed ID: 16006907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.